Torbay BRCA Micro National Leg 2 - Carisma gtb LC EMB 1

(5:26)

Dr. Traina on PARP Inhibition in BRCA-Mutated Breast Cancer

(1:17)

Germline BRCA Mutations in TNBC

(6:4)

BRCA mutation in metastatic TNBC patients

(9:32)

Sequencing in BRCA-Positive TNBC Patients

(3:3)

BRCA Micro National 2014 15 Round 2 Torbay A Final Leg 3

(6:17)

Understanding BRCA Part 2: A Survivor's Perspective

(7:1econd)

BRCA Micro Torbay 2016 round 4 A Final leg 1

(5:45)

BRCA Micro National 2014 15 Round 2 Torbay A Final Leg 1

(5:13)

Tripathy Discusses a Study of Talazoparib in BRCA-Mutated Advanced Breast Cancer

(3:27)

Olaparib and durvalumab in metastatic BRCA wild type triple-negative breast cancer

(2:57)

BRCA Micro National 2014 15 Round 2 Torbay A Final Leg 2

(5:36)

The phase 3 EMBRACA study of talazoparib in BRCA-related metastatic breast cancer

(3:52)

PARP Inhibitors for BRCA-Mutated TNBC

(5:18)

BRCA mutation in metastatic TNBC patients

(9:32)

BRCA Mutations What does it Mean When Choosing My Treatment Litton 2

(1:55)

BRCA Mutation in metastatic TNBC Patient

(20:43)

Marie Keating Foundation BRCA Conference 2020

(2:45:27)